72.19.Z - Other research and experimental development on natural sciences and engineering
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.22.Z - Specialist medical practice activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 32,1 | 8,8 | 32,5 | 271,3 |
EBITDA | 32,1 | 9,1 | 32,5 | 258,4 |
Short time liabilities | 3,1 | 5,7 | 0,8 | -86,7 |
Equity capital | 56,5 | 64,6 | 94,4 | 46,2 |
Operating profit (EBIT) | 32,1 | 9,1 | 32,5 | 258,4 |
Assets | 59,6 | 70,2 | 95,1 | 35,4 |
Net profit (loss) | 29,2 | 8 | 29,8 | 271 |
Cash | 51,1 | 58,7 | 92,2 | 57 |
Net income from sale | 47,4 | 58,4 | 53,5 | -8,4 |
Liabilities and provisions for liabilities | 3,1 | 5,7 | 0,8 | -86,7 |
Working assets | 59,6 | 70,2 | 95,1 | 35,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 51,7 | 12,4 | 31,6 | 19,2 |
Equity capital to total assets | 94,8 | 91,9 | 99,2 | 7,3 |
Gross profit margin | 67,7 | 15 | 60,7 | 45,7 |
EBITDA Margin | 67,8 | 15,5 | 60,8 | 45,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 24 | 36 | 5 | -31 |
Current financial liquidity indicator | 19.361623764038086 | 12.358362197875977 | 125.82412719726562 | 113,4 |
Net dept to EBITDA | -1.59164559841156 | -6.465407848358154 | -2.83270525932312 | 3,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane